Nara Medical University in Japan Announces World’s First Result of Research on SARS-CoV-2 and Ozone with MBT Consortium Association The research group consisted of; Professor Hisakazu YANO, Department of Microbiology and Infectious Diseases, Nara Medical University Director Kei KASAHARA, Center for Infectious Disease), Nara Medical University MBT Consortium Association (Infectious Diseases subcommittee member: Qol Holdings …

The research group consisted of;

• Professor Hisakazu YANO, Department of Microbiology and Infectious Diseases, Nara Medical University
• Director Kei KASAHARA, Center for Infectious Disease), Nara Medical University
• MBT Consortium Association (Infectious Diseases subcommittee member: Qol Holdings Co.,Ltd., Sanyu Syoji Co.,Ltd., Tamura TECO Co.,Ltd., Marusan Pharma Biotech Co.,Ltd.)

Background of the research project: There had been little or no information to prove if ozone gas could indeed defeat SARS-CoV-2.

Experiment: The SARS-CoV-2 was cultivated and applied on a stainless steel plate in an ozone-proof airtight box installed in the safety cabinet. By operating Ozonizer, the ozone concentration in the ozone-proof airtight box was controlled and maintained from 1.0 to 6.0ppm.

Result of this study: 55-60 minutes exposure the SARS-CoV-2 was inactivated. There were variable results in reference to the PPM level achieved (i.e. 1/10 -1/100 @ 1PPM and 1/10,000 @ 6PPM).

Conclusion: It was confirmed the inactivation of SARS-CoV-2 (Novel coronavirus) was achievable by exposure to ozone gas